Saroj K. Basak

1.1k total citations
33 papers, 852 citations indexed

About

Saroj K. Basak is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Saroj K. Basak has authored 33 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Saroj K. Basak's work include Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Saroj K. Basak is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (5 papers) and MicroRNA in disease regulation (5 papers). Saroj K. Basak collaborates with scholars based in United States, Japan and India. Saroj K. Basak's co-authors include Eri S. Srivatsan, Dorothee Herlyn, Mysore S. Veena, Airi Harui, Michael D. Roth, Marilene B. Wang, Raj K. Batra, Kohnosuke Mitani, Meera Srivastava and Sherven Sharma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Saroj K. Basak

30 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saroj K. Basak United States 17 368 320 262 126 102 33 852
Wolfgang Glienke Germany 16 357 1.0× 353 1.1× 421 1.6× 72 0.6× 56 0.5× 33 878
Chi‐Chen Fan Taiwan 19 423 1.1× 115 0.4× 158 0.6× 161 1.3× 40 0.4× 26 842
Philip A. Klenotic United States 16 520 1.4× 159 0.5× 79 0.3× 138 1.1× 72 0.7× 27 912
Boan Li China 22 972 2.6× 124 0.4× 256 1.0× 333 2.6× 53 0.5× 65 1.4k
Sisi He China 12 350 1.0× 213 0.7× 160 0.6× 90 0.7× 36 0.4× 19 675
Sina Taefehshokr Iran 17 324 0.9× 201 0.6× 195 0.7× 160 1.3× 21 0.2× 23 778
Rachelle Kosoff United States 12 713 1.9× 324 1.0× 263 1.0× 111 0.9× 16 0.2× 14 1.1k
Can Luo China 14 387 1.1× 210 0.7× 469 1.8× 171 1.4× 24 0.2× 32 855
Subha Philip United States 10 396 1.1× 162 0.5× 140 0.5× 157 1.2× 71 0.7× 12 766
Tianzhou Liu China 14 349 0.9× 219 0.7× 221 0.8× 119 0.9× 17 0.2× 36 865

Countries citing papers authored by Saroj K. Basak

Since Specialization
Citations

This map shows the geographic impact of Saroj K. Basak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saroj K. Basak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saroj K. Basak more than expected).

Fields of papers citing papers by Saroj K. Basak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saroj K. Basak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saroj K. Basak. The network helps show where Saroj K. Basak may publish in the future.

Co-authorship network of co-authors of Saroj K. Basak

This figure shows the co-authorship network connecting the top 25 collaborators of Saroj K. Basak. A scholar is included among the top collaborators of Saroj K. Basak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saroj K. Basak. Saroj K. Basak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Marilene B., Saroj K. Basak, Eri S. Srivatsan, et al.. (2025). Neoadjuvant APG-157 monotherapy in patients with locally advanced squamous cell carcinoma of head and neck: A phase IIA, single arm trial.. Journal of Clinical Oncology. 43(16_suppl). 6087–6087.
2.
Shin, Daniel Sanghoon, Saroj K. Basak, Mysore S. Veena, et al.. (2024). Enhanced CTLA‐4 blockade anti‐tumor immunity with APG‐157 combination in a murine head and neck cancer. Cancer Medicine. 13(9). e7212–e7212. 1 indexed citations
3.
Tosevska, Anela, Marco Morselli, Saroj K. Basak, et al.. (2022). Cell-Free RNA as a Novel Biomarker for Response to Therapy in Head & Neck Cancer. Frontiers in Oncology. 12. 869108–869108. 10 indexed citations
4.
Veena, Mysore S., Santanu Raychaudhuri, Saroj K. Basak, et al.. (2020). Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer. Journal of Biological Chemistry. 295(50). 17169–17186. 22 indexed citations
5.
Yoon, Alexander J., Haiqiang Wu, Bruce Teter, et al.. (2020). A sensitive LC-MS assay using derivatization with boron trifluoride to quantify curcuminoids in biological samples. Analytical Biochemistry. 596. 113636–113636. 9 indexed citations
6.
Venkatesan, Natarajan, Mysore S. Veena, Saroj K. Basak, et al.. (2016). Cystatin E/M Suppresses Tumor Cell Growth through Cytoplasmic Retention of NF-κB. Molecular and Cellular Biology. 36(12). 1776–1792. 19 indexed citations
7.
Basak, Saroj K., Arthur W. Wu, Natarajan Venkatesan, et al.. (2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget. 6(21). 18504–18517. 60 indexed citations
8.
Veena, Mysore S., Reason Wilken, Junying Zheng, et al.. (2014). p16 Protein and Gigaxonin Are Associated with the Ubiquitination of NFκB in Cisplatin-induced Senescence of Cancer Cells. Journal of Biological Chemistry. 289(50). 34921–34937. 24 indexed citations
9.
Basak, Saroj K., Mysore S. Veena, Scott Oh, et al.. (2013). Correction: The CD44highTumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression. PLoS ONE. 8(9). 3 indexed citations
10.
Vira, Darshni, Saroj K. Basak, Mysore S. Veena, et al.. (2012). Cancer stem cells, microRNAs, and therapeutic strategies including natural products. Cancer and Metastasis Reviews. 31(3-4). 733–751. 47 indexed citations
11.
Veena, Mysore S., Saroj K. Basak, Eugene Han, et al.. (2011). Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study. Clinical Cancer Research. 17(18). 5953–5961. 96 indexed citations
12.
Veena, Mysore S., Santanu Raychaudhuri, Huihong You, et al.. (2010). Abstract 4048: Increased expression of PACS-1 in cervical cancer is associated with loss of microRNA449a. Cancer Research. 70(8_Supplement). 4048–4048. 1 indexed citations
13.
Basak, Saroj K., Mysore S. Veena, Ge Huang, et al.. (2009). The Malignant Pleural Effusion as a Model to Investigate Intratumoral Heterogeneity in Lung Cancer. PLoS ONE. 4(6). e5884–e5884. 50 indexed citations
14.
Harui, Airi, et al.. (2006). Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of αvβ3 integrins. Journal of Leukocyte Biology. 79(6). 1271–1278. 16 indexed citations
15.
Basak, Saroj K., Sylvia M. Kiertscher, Airi Harui, & Michael D. Roth. (2004). Modifying Adenoviral Vectors for Use as Gene-Based Cancer Vaccines. Viral Immunology. 17(2). 182–196. 28 indexed citations
16.
Basak, Saroj K., Brigitte Birebent, Enkhtsetseg Purev, et al.. (2003). Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside. Cancer Immunology Immunotherapy. 52(3). 145–154. 19 indexed citations
17.
Roth, Michael D., Qingwen Cheng, Airi Harui, et al.. (2002). Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses. The Journal of Immunology. 169(8). 4651–4656. 50 indexed citations
18.
Jacob, Lutz, Rajasekharan Somasundaram, William C. Smith, et al.. (1997). Cytotoxic T‐cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. International Journal of Cancer. 71(3). 325–332. 18 indexed citations
19.
Resnicoff, Mariana, et al.. (1996). Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor antisense mRNA. Cancer Immunology Immunotherapy. 42(1). 64–68. 43 indexed citations
20.
Basak, Saroj K., Bhaskar Saha, Amal Bhattacharya, & Syamal Roy. (1992). Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell‐mediated down‐regulation of delayed‐type hypersensitivity response and up‐regulation of B cell activation. European Journal of Immunology. 22(8). 2041–2045. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfgang Glienke Breakdown of academic impact, for papers by Chi‐Chen Fan Breakdown of academic impact, for papers by Philip A. Klenotic Breakdown of academic impact, for papers by Boan Li Breakdown of academic impact, for papers by Sisi He Breakdown of academic impact, for papers by Sina Taefehshokr Breakdown of academic impact, for papers by Rachelle Kosoff Breakdown of academic impact, for papers by Can Luo Breakdown of academic impact, for papers by Subha Philip Breakdown of academic impact, for papers by Tianzhou Liu
Rankless by CCL
2026